T.H.Karlsen.2012.Genome-wide association analysis in Primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GP民35 and TCF4.Hepatology.
[0173] 6.Herbst，R.S.，J.V.Heymach'and S.M.Lippman.2008丄ung cancer.N Engl J Med 359:1367-1380.
[0174] 7. Cooper，S.，and S.G. Spiro .2006. Small cell lung cancer：treatment review.民espirology 11:241-248.
[0175] 8-Molina，J.R.，P.Yang'S.D.Cassivi，S.E.Schild，and A.A.Adjei·2008·Νοη- small cell lung cancer:epidemiology，risk factors，treatment，and survivorship.Mayo Clin Proc 83:584-594.
[0176] 9.Remon，J.，P.Lianes，S.Martinez，M.Velasco，R.Querol，and M.Zanui.2013.Malignant mesothelioma：new insights into a rare disease.Cancer Treat Rev 39:584-591.
[0177] 10.King，T.E.，Jr.，A.Pardo，and M.Selman.2011. Idiopathic pulmonary fibrosis.Lancet 378:1949-1961.
[0178] 11.Selman,M. ,A.Pardo,and T.E.King,Jr.2012.Hypersensitivity pneumonitis：insights in diagnosis and pathobiology.Am J 民espir Crit Care Med 186:314-324.
[01"79] 12 · Cosio，M · G ·，M. Saetta，and A .Agusti · 2009 · Immunologic aspects of chronic obstructive pulmonary disease.N Engl J Med 360:2445-2454.
[0180] 13.Jobe，A.H.2011.The new bronchopulmonary dysplasia.Curr Opin Pediatr 23:167-172.
[0181] 14.Kudo,M.,Y.Ishigatsubo.and I.Aoki.2013.Pathology of asthma.Front Microbiol 4:263.
[0182] 15.師ite'G.E.，A.J.Iqbal，and D.R.Greaves.2013.CC chemokine receptors and chronic inflamination--therapeutic opportunities and pharmacological challenges.Pharmacol 民ev 65:47-89.
[0183] 16·Sun，L·，and R.D·Ye·2012·Role of G protein-coupled receptors in inf lamination. Acta Pharmacol Sin 33:342-350.
[0184] 17·Vetter，I·2012·Development and optimization of FLIPR high throughput calcium assays for ion channels and GPC民s.Adv Exp Med Biol 740:45- 82.
[018日]18.Qin，Z.2012.T'he use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature.Atherosclerosis 221:2-11.
[0186] 19.Kurth，I.，K.Wi1limann，P.Schaerli，T.Hunziker，I.Clark-Lewis，and B.Moser.2001.Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine(B民AK)in macrophage development.J Exp Med 194:855-861.
[0187] 20.Burns，D.L.1988.Subunit structure and enzymic activity of pertussis toxin.Microbiol Sci 5:285-287.
[018引 21.Murphy，P.M.1996.Chemokine receptors：structure,function and role in microbial pathogenesis.Cytokine Growth Factor 民ev 7:47-64.
[0189] 22.Bokoch，G.M.1995.Chemoattractant signaling and leukocyte activation.Blood 86:1649-1660.
[0190] 23. Steele，A.D.，I.Szabo，F.Bednar，and T.J. Rogers .2002. Interactions between opioid and chemokine receptors：heterologous desensitization.Cytokine Growth Factor Rev 13:209-222.
[0191] 24.Kohout，T.A.，and R.J丄efkowitz.2003.Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization.Mol Pharmacol 63:9-18.
[0192] 25.Gouwy，M.，S.Struyf，S.Noppen，E.Schutyser，J.Y.Springael，M.Parmentier， P.Proost，and J. Van Damme .2008. Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events.Mol Pharmacol 74:485-495.
[0193] 26.Roth，R.B.，P.Hevezi，J.Lee，D.Willhite，S.lVLLechner，A.C.Foster，and A.Zlotnik.2006.Gene expression analyses reveal molecular relationships among 20 regions of the human CNS.Neurogenetics 7:67-80.
[0194] 27.Lee,J.,A.Hever^D.Willhite,A.Zlotnik,and P.Hevezi.2005.Effects of 民NA degradation on gene expression analysis of human postmortem tissues.FASEB J 19:1356-1358.
[01 巧]28.0tero，K.，A.Vecchi，E.Hirsch，J.Kearley，W.Vermi，A.Del Prete， S.Gonzalv〇-Feo，C.Garlanda，O.Azzolino，L.Salogni，C.M.Lloyd，F.Facchetti， A.Mantovani，and S.Sozzani.2010.Nonredundant role of CC民L2 in lung dendritic cell trafficking.Blood 116:2942-2949.
[0196] 29.Lee，W.Y.，C.J.Wang,T.Y.Lin，C.L.Hsiao,and C.W丄uo.2013.CXCL17，an orph過打chemoki打e，過cts過s過打ovel過打gioge打ic過打d過打ti-i打fl過mm過tory f過ctor.Am J Physiol Endocrinol Metab 304:E32-40.
[0197] 30·0'Dowd，B·F·，T·Nguyen，A.Marchese，R·Cheng，K·R·Lynch，H.H·Heng， L.F.Kolakowski，Jr.，and S.民.George.1998.Discovery of three novel G-protein- coupled receptor genes.Genomics 47:310-313.
[0198] 31.Okumura，S.，H. Baba，T.Kumada，K.Nanmoku，H.Nakaj ima，Y.Nakane，K. Hioki， and K.Ikenaka.2004.Cloning of a G-protein-coupled receptor that shows an activity to transform NIH3T3 cells and is expressed in gastric cancer cells.Cancer Sci 95:131-135.
[0199] 32·Barth，M.C.，N.Ahluwalia，T.J.Anderson，G.J.Hardy，S.Sinha，J.A.Alvarez- Cardona，I.E.Pruitt，E.P.Rhee，R.A.Colvin，andR.E.Gerszten.2009.Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions.J Biol Qiem 284:19189-19195.
[0200] 33.Yang,Y.，J.Y.Lu，X.Wu，S.Summer，J.Whoriskey，C.Saris，and J.D.民eagan.2010.G-protein-coupled receptor 35 is a target of the asthma drugs cromolyn disodium and nedocromil sodium.Pharmacology 86:1-5.
[0201 ] 34.Horikawa，Y.，N.0da，N.J.Cox，X丄i，M.0rh〇-Melander，M.Hara，Y.Hinokio， T.H.Lindner，H.Mashima，P.E.Schwarz，L.del Bosque-Plata，Y.Oda，I.Yoshiuchi， S.Colilla，K.S.Polonsky，S.Wei，P.Concannon，N.Iwasaki，J. Schulze，L.J.Baier， C.Bogardus，L.Groop，E.Boerwinkle，C.L.Hanis，and G.I.Bell.2000.Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes melliUus.Nat Genet 26:163-175.
[0202] 35.Sparfel，L.，M丄.Pinel-Marie，M.Boize，S.Koscielny，S.Desmots，A.Pery， and 0.Fardel.2010.Transcriptional signature of human macrophages exposed to the environmental contaminant benzo(a)pyrene.Toxicol Sci 114:247-259.
[0203] 36.Milligan，G.2011.Orthologue selectivity and ligand bias:translating the pharmacology of GP民35.Trends PharmacolSci 32:317-325.
[0204] 37.Deng,H.,H.Hu,and Y.Fang.2012.Multiple tyrosine metabolites are GPR35 agonists.Sci Rep 2:373.
[0205] 38.Daiyasu，H.，W.Nemoto，and H.Toh.2012. Evolutionary Analysis of Functional Divergence among Chemokine 民eceptors，Decoy 民eceptors，and Viral 民eceptors.Front Microbiol 3:264.
[0206] 39.Kim,K.M.,and M.G.Caron.2008.Complementary roles of the DRY motif and C-terminus tail of GPC民S for G protein coupling and beta-arrest in interaction.Biochem Biophys Res Commun 366:42-47.
[0207] 40.Govaerts，C.，C.Blanpain，X.Deupi，S.Ballet，J.A.Ballesteros，S.J.Wodak， G.Vassart，L. Pardo，and M.Parmentier.2001. The TXP motif in the second transmembrane helix of CCR5.A structural determinant ofchemokine-induced activation.J Biol Qiem 276:13217-13225.
[0208] 41.Cancellieri，C.，N.Caronni，A.Vacchini，B.Savino，E.M.Borroni，M丄ocati， and 民.Bonecchi.2013.民eview:Structure-function and biological properties of the atypical chemokine receptor D6.Mol Immunol 55:87-93.
[0209] 42.Wu，C.，C.Orozco，J.Boyer,Μ丄eglise，J.Goodale，S.Batalov，C丄·Hodge， J. Haase，J.Janes，J.W.Huss，3rd，and A. I.Su.2009.BioGPS:an extensible and customizable portal for querying and organizing gene annotation resources.Genome Biol 10:民 130.
[0210] 43.Murphy，P.M.，M.Baggiolini，I.F.Charo，C.A.Hebert，R.Horuk， K. Matsushima，L.H.Miller，J.J.0ppenheim，and C.A.Power.2000.International union of pharmacology.XXII.Nomenclature for chemokine receptors.Pharmacol Rev 52: 145-176.
[0211] 44 . Han，D . K.，S.Y.Jeong，Y.H.Kim，and B.G.Min.l992.Surface characteristics and blood compatibility of polyurethanes grafted by perfluoroalkyl chains.J Biomater Sci Polym Ed 3:229-241.
[0212] 45.Proudfoot，A.E.，C.A.Power，D.J.Church，D.Soler，and M.Mack.2001.Cellular assays of chemokine receptor activation.Curr Protoc Pharmacol Chapter 12：Unit 12 14.
[0213] 46.Joseph，P.R.，K.V.Sawant，A.Isley，M.Pedroza，R.P.Garofalo， 民.M.民ichardson，and K.民ajarathnam.2013.Dynamic conformational switching in the chemokine ligand is essential for G Protein coupled-receptor activation.Biochem J.
[0214] 47.Whittem，C.G.，A.D.Williams，and C.S.Williams.2010.Murine Colitis modeling using Dextran Sulfate Sodium(DSS).J Vis Exp.
[021日] 48.Perse，M.，and A.Cerar.2012.Dextran sodium sulphate colitis mouse model：traps and tricks.J Biomed Biot echnol2012:718617.
[0216] 49.Wirtz，S.，C.Neufert，B.Weigmann，and M.F.Neurath.2007.Chemically induced mouse models of intestinal inflamination.Nat Protoc 2:541-546.
[0217] 50.Kawada，M.，A.Arihiro，and E.Mizoguchi.2007.Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease.WorldJ Gastroenterol 13:5581-5593.
[0218] 51.te